Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07132775 · ClinicalTrials.gov registry record · NA

Evaluation of the Safety and Efficacy of a Full-Body Electrostimulation Garment for Individuals With Neurological and Neuromuscular Conditions That Cause Spasticity, Hyperreflexia, and Pain

A NA study of Multiple Sclerosis and Fibromyalgia, sponsored by Shirley Ryan AbilityLab.

Recruiting
Registry status
NA
Development phase
15
Enrollment target
1
Study location

NCT07132775 is a NA study of Multiple Sclerosis and Fibromyalgia that is actively recruiting participants, run by Shirley Ryan AbilityLab. The registered enrollment target is 15 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07132775, a NA study of Multiple Sclerosis and Fibromyalgia, is actively recruiting participants, sponsored by Shirley Ryan AbilityLab.

RECRUITING
Registry status
NA
Development phase
15 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to to explore the safety and efficacy of the EXOPULSE Mollii suit, a full-body electrostimulation suit, for individuals with neurological or neuromuscular conditions that cause spasticity, hyperreflexia, and/or pain.

Interventions

  • DEVICE Active full-body stimulation
  • OTHER Sham full-body stimulation

Study Locations (1)

Illinois

  • Shirley Ryan AbilityLab - Chicago

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2025-07-23
Est. Completion 2027-07
Phase NA

Sponsor

Shirley Ryan AbilityLab

138 total trials

What the Registry Record Tells You About NCT07132775

The ClinicalTrials.gov registry entry for NCT07132775 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (97% lower). The listed sponsor is Shirley Ryan AbilityLab, which has 138 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Multiple Sclerosis appearing as the primary indexed condition, and to 2 interventions - of which Active full-body stimulation is the first listed.

NCT07132775 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT07132775 about?

NCT07132775 is a clinical study titled "Evaluation of the Safety and Efficacy of a Full-Body Electrostimulation Garment for Individuals With Neurological and Neuromuscular Conditions That Cause Spasticity, Hyperreflexia, and Pain". The purpose of this study is to to explore the safety and efficacy of the EXOPULSE Mollii suit, a full-body electrostimulation suit, for individuals with neurological or neuromuscular conditions that cause spasticity, hyperreflexia, and/or pain.

What is the current status of trial NCT07132775?

This trial is currently recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2025-07-23. Estimated completion is 2027-07.

What conditions does trial NCT07132775 study?

This clinical trial studies the following conditions: Multiple Sclerosis, Fibromyalgia, Neurologic Disorder, Neuromuscular Disorders.

What interventions are being tested in trial NCT07132775?

The interventions under investigation include: Active full-body stimulation (DEVICE), Sham full-body stimulation (OTHER).

Who is sponsoring clinical trial NCT07132775?

This trial is sponsored by Shirley Ryan AbilityLab, which has 138 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07132775 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Multiple Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.